Mercedes Porosnicu to Vesicular stomatitis Indiana virus
This is a "connection" page, showing publications Mercedes Porosnicu has written about Vesicular stomatitis Indiana virus.
Connection Strength
0.842
-
Westcott MM, Liu J, Rajani K, D'Agostino R, Lyles DS, Porosnicu M. Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis. J Virol. 2015 Aug; 89(15):7944-54.
Score: 0.512
-
Porosnicu M, Mian A, Barber GN. The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene. Cancer Res. 2003 Dec 01; 63(23):8366-76.
Score: 0.231
-
Fernandez M, Porosnicu M, Markovic D, Barber GN. Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease. J Virol. 2002 Jan; 76(2):895-904.
Score: 0.051
-
Balachandran S, Porosnicu M, Barber GN. Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or myc function and involves the induction of apoptosis. J Virol. 2001 Apr; 75(7):3474-9.
Score: 0.048